Authors:
BRIELMEIER M
BECHET JM
FALK MH
PAWLITA M
POLACK A
BORNKAMM GW
Citation: M. Brielmeier et al., IMPROVING STABLE TRANSFECTION EFFICIENCY - ANTIOXIDANTS DRAMATICALLY IMPROVE THE OUTGROWTH OF CLONES UNDER DOMINANT MARKER SELECTION, Nucleic acids research, 26(9), 1998, pp. 2082-2085
Citation: K. Felix et al., TETRAVINYL-TETRAMETHYLCYCLO-TETRASILOXANE (TETRAVINYL D4) IS A MUTAGEN IN RAT2-LAMBDA-LACI FIBROBLASTS, Carcinogenesis, 19(2), 1998, pp. 315-320
Authors:
SAKAI T
TANIGUCHI Y
TAMURA K
MINOGUCHI S
FUKUHARA T
STROBL LJ
ZIMBERSTROBL U
BORNKAMM GW
HONJO T
Citation: T. Sakai et al., FUNCTIONAL REPLACEMENT OF THE INTRACELLULAR REGION OF THE NOTCH1 RECEPTOR BY EPSTEIN-BARR-VIRUS NUCLEAR ANTIGEN-2, Journal of virology, 72(7), 1998, pp. 6034-6039
Authors:
FALK MH
MEIER T
ISSELS RD
BRIELMEIER M
SCHEFFER B
BORNKAMM GW
Citation: Mh. Falk et al., APOPTOSIS IN BURKITT-LYMPHOMA CELLS IS PREVENTED BY PROMOTION OF CYSTEINE UPTAKE, International journal of cancer, 75(4), 1998, pp. 620-625
Citation: K. Felix et al., ASSOCIATION OF ELEVATED MUTAGENESIS IN THE SPLEEN WITH GENETIC SUSCEPTIBILITY TO INDUCED PLASMACYTOMA DEVELOPMENT IN MICE, Cancer research, 58(8), 1998, pp. 1616-1619
Authors:
ALTMEYER A
SIMMONS RC
KRAJEWSKI S
REED JC
BORNKAMM GW
CHENKIANG S
Citation: A. Altmeyer et al., REVERSAL OF EBV IMMORTALIZATION PRECEDES APOPTOSIS IN IL-6-INDUCED HUMAN B-CELL TERMINAL DIFFERENTIATION, Immunity, 7(5), 1997, pp. 667-677
Citation: K. Felix et al., IN-VITRO MUTAGENICITY OF THE PLASMACYTOMAGENIC AGENT PRISTANE (2,6,10,14-TETRAMETHYLPENTADECANE), Cancer letters, 113(1-2), 1997, pp. 71-76
Authors:
STROBL LJ
HOFELMAYR H
STEIN C
MARSCHALL G
BRIELMEIER M
LAUX G
BORNKAMM GW
ZIMBERSTROBL U
Citation: Lj. Strobl et al., BOTH EPSTEIN-BARR VIRAL NUCLEAR ANTIGEN-2 (EBNA2) AND ACTIVATED NOTCH1 TRANSACTIVATE GENES BY INTERACTING WITH THE CELLULAR PROTEIN RBP-JK, Immunobiology, 198(1-3), 1997, pp. 299-306
Authors:
LINDNER H
HOLLER E
GERBITZ A
JOHNSON JP
BORNKAMM GW
EISSNER G
Citation: H. Lindner et al., INFLUENCE OF BACTERIAL-ENDOTOXIN ON RADIATION-INDUCED ACTIVATION OF HUMAN ENDOTHELIAL-CELLS IN-VITRO AND IN-VIVO - INTERLEUKIN-10 PROTECTS AGAINST TRANSENDOTHELIAL MIGRATION, Transplantation, 64(9), 1997, pp. 1370-1373
Citation: J. Mautner et al., LONG-RANGE CHROMATIN ANALYSIS OF THE HUMAN MYC LOCUS BY PULSED-FIELD GEL-ELECTROPHORESIS, Genes, chromosomes & cancer, 16(4), 1996, pp. 247-253
Authors:
MAUTNER J
BEHRENDS U
HORTNAGEL K
BRIELMEIER M
HAMMERSCHMIDT W
STROBL L
BORNKAMM GW
POLACK A
Citation: J. Mautner et al., C-MYC EXPRESSION IS ACTIVATED BY THE IMMUNOGLOBULIN KAPPA-ENHANCERS FROM A DISTANCE OF AT LEAST 30 KB BUT NOT BY ELEMENTS LOCATED WITHIN 50KB OF THE UNALTERED C-MYC LOCUS IN-VIVO, Oncogene, 12(6), 1996, pp. 1299-1307
Authors:
FUNK JO
HOLLER E
KOHLHUBER F
UEFFING M
BORNKAMM GW
KIND P
EISSNER G
Citation: Jo. Funk et al., PROTEIN-KINASE-C ACTIVATION IS INVOLVED IN ULTRAVIOLET-B IRRADIATION-INDUCED ENDOTHELIAL-CELL ICAM-1 UP-REGULATION AND LYMPHOCYTE-ENDOTHELIUM INTERACTION IN-VITRO, Scandinavian journal of immunology, 44(4), 1996, pp. 354-360
Authors:
ZIMBERSTROBL U
KEMPKES B
MARSCHALL G
ZEIDLER R
VANKOOTEN C
BANCHEREAU J
BORNKAMM GW
HAMMERSCHMIDT W
Citation: U. Zimberstrobl et al., EPSTEIN-BARR-VIRUS LATENT MEMBRANE-PROTEIN (LMP1) IS NOT SUFFICIENT TO MAINTAIN PROLIFERATION OF B-CELLS BUT BOTH IT AND ACTIVATED CD40 CANPROLONG THEIR SURVIVAL, EMBO journal, 15(24), 1996, pp. 7070-7078
Authors:
JOCHNER N
EICK D
ZIMBERSTROBL U
PAWLITA M
BORNKAMM GW
KEMPKES B
Citation: N. Jochner et al., EPSTEIN-BARR-VIRUS NUCLEAR ANTIGEN-2 IS A TRANSCRIPTIONAL SUPPRESSOR OF THE IMMUNOGLOBULIN MU GENE - IMPLICATIONS FOR THE EXPRESSION OF THETRANSLOCATED C-MYC GENE IN BURKITTS-LYMPHOMA CELLS, EMBO journal, 15(2), 1996, pp. 375-382
Authors:
EISSNER G
LINDNER H
BEHRENDS U
KOLCH W
HIEKE A
KLAUKE I
BORNKAMM GW
HOLLER E
Citation: G. Eissner et al., INFLUENCE OF BACTERIAL-ENDOTOXIN ON RADIATION-INDUCED ACTIVATION OF HUMAN ENDOTHELIAL-CELLS IN-VITRO AND IN-VIVO - PROTECTIVE ROLE OF IL-10, Transplantation, 62(6), 1996, pp. 819-827
Authors:
POLACK A
HORTNAGEL K
PAJIC A
CHRISTOPH B
BAIER B
FALK M
MAUTNER J
GELTINGER C
BORNKAMM GW
KEMPKES B
Citation: A. Polack et al., C-MYC ACTIVATION RENDERS PROLIFERATION OF EPSTEIN-BARR-VIRUS (EBV)-TRANSFORMED CELLS INDEPENDENT OF EBV NUCLEAR ANTIGEN-2 AND LATENT MEMBRANE-PROTEIN-1, Proceedings of the National Academy of Sciences of the United Statesof America, 93(19), 1996, pp. 10411-10416
Authors:
KEMPKES B
ZIMBERSTROBL U
EISSNER G
PAWLITA M
FALK M
HAMMERSCHMIDT W
BORNKAMM GW
Citation: B. Kempkes et al., EPSTEIN-BARR-VIRUS NUCLEAR ANTIGEN-2 (EBNA2)-ESTROGEN RECEPTOR FUSIONPROTEINS COMPLEMENT THE EBNA2-DEFICIENT EPSTEIN-BARR-VIRUS STRAIN P3HR1 IN TRANSFORMATION OF PRIMARY B-CELLS BUT SUPPRESS GROWTH OF HUMAN B-CELL LYMPHOMA LINES, Journal of General Virology, 77, 1996, pp. 227-237
Citation: C. Rottleb et al., STRUCTURE-ACTIVITY RELATIONSHIP OF 17 STRUCTURAL ANALOGS OF N-BUTYRICACID UPON C-MYC EXPRESSION, International journal of cancer, 67(5), 1996, pp. 724-729
Authors:
EISSNER G
KOHLHUBER F
GRELL M
SCHEURICH P
HIEKE A
BORNKAMM GW
HOLLER E
Citation: G. Eissner et al., BACTERIAL-ENDOTOXIN SENSITIZES HUMAN ENDOTHELIAL-CELLS AGAINST RADIATION-INDUCED PROGRAMMED CELL-DEATH THROUGH THE ACTION OF TRANSMEMBRANE TNF-ALPHA, European journal of cancer, 31A, 1995, pp. 41-41
Authors:
EISSNER G
GRELL M
HIEKE A
UEFFING M
SCHEURICH P
BORNKAMM GW
HOLLER E
Citation: G. Eissner et al., ENDOTHELIAL-CELLS UNDERGO PROGRAMMED CELL-DEATH IN RESPONSE TO IONIZING-RADIATION AND ENDOTOXIN-ROLE OF TRANSMEMBRANE TNF-ALPHA, Experimental hematology, 23(8), 1995, pp. 889-889
Authors:
KEMPKES B
SPITKOVSKY D
JANSENDURR P
ELLWART JW
KREMMER E
DELECLUSE HJ
ROTTENBERGER C
BORNKAMM GW
HAMMERSCHMIDT W
Citation: B. Kempkes et al., B-CELL PROLIFERATION AND INDUCTION OF EARLY G(1)-REGULATING PROTEINS BY EPSTEIN-BARR-VIRUS MUTANTS CONDITIONAL FOR EBNA2, EMBO journal, 14(1), 1995, pp. 88-96
Authors:
BOUVIER G
HERGENHAHN M
POLACK A
BORNKAMM GW
DETHE G
BARTSCH H
Citation: G. Bouvier et al., CHARACTERIZATION OF MACROMOLECULAR LIGNINS AS EPSTEIN-BARR-VIRUS INDUCER IN FOODSTUFF ASSOCIATED WITH NASOPHARYNGEAL CARCINOMA RISK, Carcinogenesis, 16(8), 1995, pp. 1879-1885